Abstract
Purpose
Gender assignment represents one of the most controversial aspects of the clinical management of individuals with Differences of Sex Development, including 5α-Reductase-2 deficiency (SRD5A2). Given the predominant female appearance of external genitalia in individuals with SRD5A2 deficiency, most of them were assigned to the female sex at birth. However, in the last years the high rate of gender role shift from female to male led to recommend a male gender assignment.
Methods
We here describe two cases of subjects with SRD5A2 deficiency assigned as females at birth, reporting their clinical histories and psychometric evaluations (Body Uneasiness Test, Utrecht Gender Dysphoria Scale, Bem Sex-Role Inventory, Female Sexual Distress Scale Revised, visual analogue scale for gender identity and sexual orientation) performed at the time of referral at the Florence Gender Clinic.
Results
Both patients underwent early surgical interventions without being included in the decision-making process. They had to conform to a binary feminine gender role because of social/familiar pressure, with a significant impact on their psychological well-being. Psychometric evaluations identified clinically significant body uneasiness and gender incongruence in both subjects. No sexually related distress and undifferentiated gender role resulted in the first subject and sexually related distress and androgynous gender role resulted in the second subject.
Conclusions
The reported cases suggest the possibility to consider a new approach for gender assignment in these individuals, involving them directly in the decision-making process and allowing them to explore their gender identity, also with the help of GnRH analogues to delay pubertal modifications.
References
Hughes I, Houk C, Ahmed SF, Lee PA, LWEPS Consensus Group, ESPE Consensus Group (2006) Consensus statement on management of intersex disorders. Arch Dis Child 91:554–563
Sandberg DE, Gardner M, Callens N, Muzur T, DSD-TRN Psychosocial Workgroup, the DSD-TRN Advocacy Advisory Network, and Accord Alliance (2017) Interdisciplinary care in disorders/differences of sex development (DSD). The psychosocial component of the DSD-Translational research network. Am J Med Genet C 175(2):279–292
Wilson JD, Griffin JE, Russell DW (1993) Steroid 5alpha-reductase 2 deficiency. Endocr Rev 14:577–593
Wigley WC, Prihoda JS, Mowszowicz I, Mendonca BB, New MI et al (1994) Natural mutagenesis study of the human steroid 5 alpha-reductase 2 isozyme. Biochemistry 33:1265–1270
Cheon CK (2011) Practical approach to steroid 5 alpha-reductase type 2 deficiency. Eur J Pediatr 170:1–8
Imperato-McGinley J et al (1974) Steroid 5alpha-reductase deficiency in men: an inherited form of male pseudohermaphroditism. Science 186(4170):1213–1215
Imperato-McGinley J, Peterson RE, Gautier T, Sturla E (1979) Male pseudohermaphroditism secondary to 5α-reductase deficiency: a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity. J Steroid Biochem Mol Biol 11:37–45
Hiort O, Reinecke S, Thyen U, Jürgensen M, Holterhus PM et al (2003) Puberty in disorders of somatosexual differentiation. J Pediatr Endocrinol Metab 16:297–306
Sinnecker GH, Hiort O, Dibbelt L, Albers N, Dorr HG et al (1996) Phenotypic classification of male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Am J Med Genet 63:223–230
Maimoun L, Philibert P, Cammas B, Audran F, Bouchard P et al (2011) Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab 96:296–307
Chan AO, But BW, Lee CY, Lam YY, Ng KL et al (2013) Diagnosis of 5α-reductase 2 deficiency: is measurement of dihydrotestosterone essential? Clin Chem 59:798–806
Fisher AD, Ristori J, Fanni E, Castellini G, Forti G, Maggi M (2016) Gender identity, gender assignement and reassignement in individuals with disorders of sex development: a major dilemma. J Endocrinol Invest 39(11):1207–1224
Cohen-Kettenis PT (2005) Gender change in 46, XY persons with 5alfa-reductase-2 deficiency and 17alpha-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav 34:399–410
Cuzzolaro M, Vetrone G, Marano G, Battacchi MW (1999) BUT, Body Uneasiness test: anewattitudinal body image scale. Psichiatr Infanz Adolesc 66:417–428
Cohen-Kettenis PT, van Goozen SH (1997) Sex reassignment of adolescent transsexuals: a follow-up study. J Am Acad Child Adolesc Psychiatry 36(2):263–271
Bem SL (1974) The measurement of psychological androgyny. J Consult Clin Psychol 2:155–162
Derogatis L, Clayton A, Lewis-D’Agostino D, Wunderlich G, Fu Y (2008) Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 5(2):357–364
Fisher AD, Castellini G, Casale H, Fanni E, Bandini E, Campone B, Ferruccio N, Maseroli E, Boddi V, Dèttore D, Pizzocaro A, Balercia G, Oppo A, Ricca V, Maggi M (2015) Hypersexuality, paraphilic behaviors, and Gender Dysphoria in individuals with Klinefelter’s Syndrome. J Sex Med 12(2):2413–2424
Yildiz BO, Bolour S, Woods K, Moore A, Azziz R (2010) Visually scoring hirsutism. Hum Reprod Update 16:51–64
Bertelloni S, Russo G, Baroncelli GI (2018) Human Chorionic Gonadotropin test: old uncertainties, new perspectives, and value in 46, XY Disorders of Sex Development. Sex Dev 12:41–49
Verkauf BS, Von Thron J, O’Brien WF (1992) Clitoral size in normal women. Obstet Gynecol 80:41–44
Thigpen AE, Davis DL, Milatovich A, Mendonca BB, Imperato-McGinley J, Griffin JE, Francke U, Wilson JD, Russell DW (1992) Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest 90(3):799–809
Bertelloni S, Baldinotti F, Russo G, Ghirri P, Dati E, Michelucci A, Moscuzza F, Meroni S, Colombo I, Sessa MR, Baroncelli GI (2016) 5alpha-Reductase-2 Deficiency: clinical findings, endocrine pitfalls, and genetic features in a large Italian cohort. Sex Dev 10(1):28–36
Bouvattler C, Mignot B, Lefevre H, Morel Y, Bougneres P (2006) Impaired sexual activity in male adults with partial androgen insensitivity. J Clin Endocrinol Metab 91:3310–3315
Hooper HT, Figuiredo BC, Pavan-Senn CC, de Lacerca L, Sandrini R, Mengarelli JK, Japp K, Karaviti LP (2004) Concordance of phenotypic expression and gender identity in a large kindred with a mutation in the androgen receptor. Clin Genet 65:183–190
Jürgensen M, Kleinemeier E, Lux A, Steemsa TD, Cohen-Kettenis PT, Hiort O, Thyen U, DSD Network Working Group (2010) Psychosexual development in children with disorder of sex development—results from the German Clinical Evaluation Study. J Pediatr Endocrinol Metab 23:565–578
Jürgensen M, Lux A, Wien SB, Kleinemeier E, Hiort O, Thyen U (2014) Health-related quality of life in children with disorders of sex development (DSD). Eur J Pediatr 173:893–903
Mazur T, Sandberg DE, Perrin MA, Gallagher JA, MacGillivray MH (2004) Male pseudohermaphroditism: long-term quality of life outcome in five 46, XY individuals reared female. J Pediatr Endocrinol Metab 17:809–823
Migeon CJ, Wisniewski AB, Gearhart JP, Meyer-Bahlburg HF, Rock JA, Brown TR, Casella SJ, Maret A, Ngai KM, Money J, Berkovitz GD (2002) Ambiguous genitalia with perineo-scrotal hypospadias in 46, XY individuals: long-term medical, surgical and psychosexual outcome. Pediatrics 110:e31
Byers HM, Mohnach LH, Fechner PY, Chen M, Thomas IH, Ramsdell LA, Shnorhavorian M, McCauley EA, Amies Oelschlager AE, Park JM, Sandberg DE, Adam MP, Keegan CE (2017) Unexpected ethical dilemmas in sex assignment in 46, XY DSD due to 5-alpha reductase type 2 deficiency. Am J Med Genet C 175(2):260–267
Kreukels BPC, Köhler B, Nordenström A, Roehle R, Thyen U, Bouvattier C, de Vries ALC, Cohen-Kettenis PT, dsd-LIFA group (2018) Gender dysphoria and gender change in disorders of sex development/intersex conditions: results from the dsd-LIFE Study. J Sex Med 15(5):777–785
Khorashad BS, Aghili Z, Kreukels BP et al (2016) Psychosexual outcome among Iranian individuals with 5α-reductase deficiency type 2 and its relationship with parental sexism. J Sex Med 13:1629–1641
Kolesinska Z, Ahmed SF, Niedziela M, Bryce J, Molinska-Glura M, Rodie M, Weintrob N (2014) Changes over time in sex assignment for disorders of sex development. Pediatrics 134(3):e710–e715
Money J (1975) Ablatio penis: normal male infant sex-reassigned as a girl. Arch Sex Behav 4(1):65–71
Yang JH, Baskin LS, Disandro M (2010) Gender identity in disorders of sex development: review article. Urology 75:153–159
Achermann JC, Hughes IA (2008) Disorders of sex development. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds) Williams textbook of endocrinology, 11th edn. Elsevier Saunders, Philadelphia.
Phoenix CH, Goy RW, Gerall AA, Young WC (1959) Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Endocrinology 65:369–382
Lee PA, Nordenström A, Houk CP, Ahmed SF, Auchus R, Baratz A, Baratz Dalke K, Liao LM, Lin-Su K, Looijenga III LH, Mazur T, Meyer-Bahlburg HF, Mouriquand P, Quigley CA, Sandberg DE, Vilain E, Witchel S, Global DSD update consortium (2016) Global disorders of sex development update since 2006: perceptions, approach and care. Horm Res Paediatr 85:158–180
Mendonca BB, Domenice S, Arnhold IJ, Costa EM (2009) 46, XY disorders of sex development (DSD). Clin Endocrinol 70:173–187
Sasaki G, Nakagawa K, Hashiguchi A, Hasegawa T, Ogata T, Murai M (2003) Giant seminoma in a patient with 5 alpha-reductase type 2 deficiency. J Urol 169(3):1080–1081
Cools M, Looijenga LH, Wollfenbuttel KP, Drop SL (2009) Disorders of sex development: update on the genetic background, terminology and risk for the development of germ cell tumors. World J Pediatr 5:93–102
Nascimento RLP, de Andrade-Mesquita IM, Gondim R, Dos Apçstolos RAAC, Toralles MB, de Oliveira LB, Canguçu-Campinho AK, Barroso U Jr (2018). Gender identity in patients with 5-alpha reductase deficiency raised as females. J Pediatr Urol 14(5):419e1-419e6.
DiSandro M, Merke DP, Rink RC (2015) Review of current surgical techniques and medical management considerations in the treatment of pediatric patients with disorders of sex development. Horm Metab Res 47:321–328
Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T’Sjoen G (2017) Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 102(11):3869–3903
Acknowledgement
Dr. Cindy Degli Innocenti o Cresciuti has been acknowledged for data collection.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no potential conflict of interest.
Ethical approval
The study protocol was approved by the Institution’s Ethics Committee.
Informed consent
All patients included in this study provided their informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cocchetti, C., Ristori, J., Mazzoli, F. et al. 5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature. J Endocrinol Invest 43, 1131–1136 (2020). https://doi.org/10.1007/s40618-020-01193-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-020-01193-w